ASCEPT Fellows

Professor Rebecca Ritchie
Awarded 2024

Professor Dominic Geraghty
Awarded 2024

Professor Donald Birkett
Awarded 2024

Professor Michael McManus
Awarded 2024

Professor Michael Roberts
Awarded 2023

Professor David Le Couteur
Awarded 2023

Professor Gillian Shenfield
Awarded 2023

Professor Richard Day
Awarded 2022
Professor Roger Summers
Awarded 2022
Emeritus Professor Andrew Somogyi
Awarded 2021
Emeritus Professor Felix Bochner
Awarded 2021
Professor Kathie Knights
Awarded 2020
Professor Graham Johnston
Awarded 2020
Professor Mary Collins (Chebib)
Awarded 2019
Professor Emeritus Nick Holford
Awarded 2019
Professor John Miners
Awarded 2019
Professor Evan Begg
Awarded 2019
Fellow Member
Fellow membership is only available to existing Ordinary Members, Life Members or Retired Members. Further, to be a Fellow Member, the person must:
(a) have been a Member of ASCEPT for more than 5 years;
(b) have made a significant contribution to ASCEPT or have provided distinguished service to ASCEPT; and
(c) have provided distinguished service to the advancement of pharmacology and toxicology research and/or education and/or outreach.
To be a Fellow Member, the person must be nominated for this position and be recommended by a majority of the Fellow Membership Committee.
The Fellow Membership Committee is established under clause 47 (b) of the constitution. The committee will include the President, and either the President-Elect or the Immediate Past President (whoever is on the board at the time), and any three Fellow Members or former Presidents of ASCEPT.
Up to four Fellow Members are allowed to be admitted to ASCEPT each year, unless there are exceptional circumstances.
Click here for the nomination form and guidelines.
Nominations will be announced to the membership via email each year and must be submitted by the specified deadline.
Life Fellow Member
This membership class is open to a Fellow Member who has retired, or is still working but has reached the age of 65.
To be a Life Fellow Member, the person must be recommended by the Board and approved by a majority of Members at an annual general meeting of the company.